Silencing YB-1 induces cisplatin sensitization in neuroblastoma (Wang H. et al., 2017), esophageal SCC (Xu and Hu, 2016), bladder cancer (Shiota et al., 2011) and melanoma (Schittek et al., 2007). The gene discussed is YBX1; the disease is urinary bladder cancer.